Interoception refers collectively to the processing of internal bodily stimuli by the nervous system. Parcellation of the nervous system's processing of sensory signals into interoception, proprioception, and exteroception began more than 100 years ago ([@R1]), although it was predated by interest in linking body--brain interactions with conscious experience ([@R2],[@R3]). Scientific interest in interoception has fluctuated ([Figure 1A](#F1){ref-type="fig"}). During the 1980s, biological psychiatry was inundated with observations of interoceptive disturbances in panic disorder ([@R4]--[@R7]), although the trend receded after it became clear that the etiological mechanism was broader than a single molecular receptor target ([@R8]). Recent years have witnessed a surge of interest on the topic of interoception due in part to findings highlighting its integral role in emotional experience, self-regulation, decision making, and consciousness. Importantly, interoception is not limited to conscious perception or even unique to the human species. From this perspective, interdisciplinary efforts to understand different features of interoception have been essential for advancing progress in cognitive and clinical neuroscience ([Figure 1B](#F1){ref-type="fig"}).

ASSESSMENT {#S1}
==========

Body Systems of Interoception {#S2}
-----------------------------

Interoceptive processing occurs across all major biological systems involved in maintaining bodily homeostasis, including the cardiovascular ([@R9],[@R10]), pulmonary ([@R11]), gastrointestinal ([@R12],[@R13]), genitourinary ([@R14]), nociceptive ([@R15]), chemosensory ([@R16]), osmotic ([@R17]), thermoregulatory ([@R18]), visceral^[1](#FN2){ref-type="fn"}^ ([@R19]), immune ([@R20],[@R21]), and autonomic systems ([@R22],[@R23]) ([Table 1](#T1){ref-type="table"}). There has been relatively little focus overall on the integration across bodily systems; thus, it is not surprising that most investigations of the topic have been siloed within distinct research areas or scientific disciplines \[see ([@R24],[@R25]) for noteworthy exceptions\].

Features of Interoception {#S3}
-------------------------

Interoception is not a simple process but rather has several facets ([@R26]). The act of sensing, interpreting, and integrating information about the state of inner body systems can be related to different elements such as interoceptive attention, detection, discrimination, accuracy, insight, sensibility, and self-report ([Table 2](#T2){ref-type="table"}). However, most interoceptive processes occur outside the realm of conscious awareness. Consciously experienced elements are measured clinically via subjective report, and there are few observable interoceptive signs (e.g., heart rate, respiration rate, pupillary dilation, flushing, perspiration, piloerection, nociceptive reflexes) ([Table 3](#T3){ref-type="table"}). Experimental approaches can quantify different body systems and features of interoceptive processing. Nevertheless, these measures are only partially overlapping and likely reflect somewhat distinct neural processes ([@R27]). Access to the full range of interoceptive signals often involves invasive approaches, which tend to elicit physiological perturbations and index more objectively measurable features ([@R28]). However, many insights have been gained by the application of noninvasive approaches within neuroscience and psychological assessment contexts ([@R29]) (see "Eavesdropping on Brain--Body Communication" section below).

Importance of an Interoceptive Taxonomy {#S4}
---------------------------------------

There is no generally agreed-on taxonomy for interoception science. Variable definitions have made it difficult to identify the features under investigation, let alone evaluate the quality of the findings. Based on the number of physiological systems involved, it could be questioned whether the terms "interoception" and "interoceptive awareness" are too broad. Interoceptive awareness is an umbrella term that was first used to describe a self-report subscale ([@R30]), but it has subsequently been used to encompass any (or all) of the different interoception features accessible to conscious self-report. Researchers from different fields developed definitions that only partially overlapped, reflecting the need for operationalization in neuroscience ([@R31],[@R32]) and clinical practice ([@R33],[@R34]). Here we develop a more coherent nomenclature for its various components ([Table 2](#T2){ref-type="table"}), mirroring developments in other fields, especially pain ([@R35]). One key aspect is the importance of distinguishing sensation (i.e., the raw signals conveyed by bodily sensors) from perception ([@R36],[@R37]). We return to this theme below.

Multilevel Investigations {#S5}
-------------------------

While interoception research to date has typically focused on single organ systems, an expanded approach that assesses multiple interoceptive organ systems and/or elements is needed. Examples include targeting numerous interoceptive features simultaneously and employing different tasks that converge on the same feature (e.g., combining top-down assessments of interoceptive attention with bottom-up perturbation approaches in the same individual) ([Figure 2A](#F2){ref-type="fig"}).

Sensing Perturbations {#S6}
---------------------

The inner and outer worlds of the body constantly fluctuate. The nervous system monitors these environmental changes and responds adaptively in order to maintain a homeostatic balance and promote survival. Because psychiatric disorders often promote or reflect the development of chronic homeostatic and allostatic disturbances ([@R38]), there is a need for methods capable of eliciting homeostatic perturbations in controlled settings, especially those assessing subjective and behavioral responses to valence and arousal deviations. However, interoception is not simply about afferent processing. The brain's constant monitoring of the body occurs in service of optimizing homeostatic regulation. This efferent limb is understudied ([@R39]), and paradigms that can effectively measure visceromotor outputs will be critical to establish sensitive assays of dysfunctional interoception and homeostatic regulation (e.g., detection of visceromotor-efferent neural signals controlling baroreflex sensitivity during modulation of visceral-afferent input by sympathetic drugs). The reliability and validity of methods should be rigorously established.

INTEGRATION {#S7}
===========

Interoception and Domain Specificity Within the Brain {#S8}
-----------------------------------------------------

There are fundamentally differing ways to interpret the evolution of brain and body signaling in humans. The processing of interoceptive input could be domain specific, with modular processing occurring in specialized, encapsulated neural circuits \[e.g., cardiac, respiratory, urinary, genital, chemical, hormonal; see ([@R40]) for a review of domain specificity\] or functionally coupled (e.g., cardiorespiratory, genitourinary, chemohormonal) and integrated within a single neural circuit. Understanding the adaptive origins and functions of interoceptive domain specidicity (if present) could tell us how the implementation and deployment of interoceptive signals by the nervous system contributes to disordered mental health. Because interoceptive signaling involves afferent and efferent inputs across multiple hierarchies within the autonomic and central nervous systems, identifying where and how information processing dysfunctions negatively affect mental health represents a challenging problem.

Neural Pathways of Interoception {#S9}
--------------------------------

Several pathways have been implicated in the neural processing of interoceptive signals, beginning with a rich interface between autonomic afferents and the central nervous system. Relay pathways involve primarily spinal, vagal, and glossopharyngeal afferents, with multiple levels of processing and integration in autonomic ganglia and spinal cord ([@R10],[@R19],[@R22],[@R41]). Several brainstem (nucleus of the solitary tract, parabrachial nucleus, and periaqueductal gray), subcortical (thalamus, hypothalamus, hippocampus, and amygdala), and cortical regions (insula and somatosensory cortices) represent key afferent processing regions ([@R22],[@R42],[@R43]). A complementary set of regions involved in visceromotor actions represents key efferent processing regions, including the anterior insula, anterior cingulate, subgenual cingulate, orbitofrontal, ventromedial prefrontal, supplementary motor, and premotor areas ([@R44]--[@R46]). It is noteworthy that these neural regions coincide closely with other sensory processing systems, especially the nociceptive and affective systems. The degree to which these represent distinct or overlapping systems is currently unclear.

Linking Paradigms Across Units of Analysis {#S10}
------------------------------------------

A particular challenge when examining interoception is the fact that afferent sensory signals are integrated on several levels (peripherally, within the spinal cord, and supraspinally) to form sets of interoceptive maps across different body systems. The brain appears to integrate information representing particular states of multiple systems simultaneously (cardiac, respiratory, chemical, hormonal, nociceptive, etc.) ([@R41]), and it is imperative to be able to model and comparatively evaluate such mappings ([Figure 2B](#F2){ref-type="fig"}). This poses many challenges. One approach might be to apply measures that assess multiple organ systems or interoceptive features simultaneously \[see ([@R42],[@R47],[@R48])\] or to record activity across the brain, spinal cord, and peripheral organs ([@R49]). However, it is also possible that multisystem assessments may reduce specificity for certain disorders and therefore may be unnecessary. For example, some patients with panic disorder may experience dyspnea but not palpitations. Localizing and then targeting the dysfunctional interoceptive domain would become more useful than broad multisystem interventions.

Timing and Rhythm in Interoceptive Circuits {#S11}
-------------------------------------------

The physiological timescales and amplitudes of interoceptive signaling vary dramatically (e.g., heart rate \[0.5--3.3 Hz\], respiratory rate \[0.08--1 Hz\], gastric contractility \[0.05--0.1 Hz\], urinary frequency \[0.000045--0.00012 Hz\]), with even slower changes in humoral mediators ([@R50]) ([Figure 2C, D](#F2){ref-type="fig"}). They also vary across individuals, and over the life span (e.g., increased heart rates in infants/children). Despite the variance, the brain tracks such changes in similar subregions, including the insula, somatosensory cortices, cingulate, amygdala, thalamus, and brainstem ([@R42],[@R43],[@R51]--[@R53]). Temporal synchrony or dyssynchrony between these systems may affect interoceptive experiences, affect, and behavior, although the exact mechanisms require further study ([@R54]). Repetitive events are another important element for learning, and while there are numerous classic studies on visceral learning at the peripheral organ system level ([@R55],[@R56]), we know little about the central mapping of learned visceral memories, especially in psychiatric disorders ([@R57]).

How Can Animal Research Improve the Understanding of Human Interoceptive Processing? {#S12}
------------------------------------------------------------------------------------

Although the inability to measure the subjective state of animals results in indirect inferences, well-established tasks exist \[e.g., conditioned interoceptive place preference ([@R58]) and odor aversion ([@R59])\]. The principal utility of animal models is the hypothesis testing of mechanistic processes at the biological level independent of appraisal and cognition. These include examining effects of peripheral or central nervous system lesions on physiology/behavior, or mapping of peripheral/central interactions via stimulation of selective neurons/circuits using optogenetic methods ([@R60],[@R61]), and targeted gene expression manipulation to test genetic hypotheses ([@R62]). Animal models are advantageous in that they allow for identification of neural mechanisms that may be distinct from higher cognitive processes (e.g., nonmammalian \[reptiles/birds\] vs. mammalian \[mice/rats/monkeys/apes/chimpanzees\], invertebrate \[octopus\] vs. vertebrate \[fish/monkeys\]). The study of interoception in nonhuman primates offers intriguing opportunities. Investigations in this area have been centered primarily on neural encoding of baroreceptor afferent stimulation ([@R9]) and neuroanatomical circuit tracing ([@R63]). Fewer studies have examined relationships between mechanistic manipulation of interoceptive experiences and neural representation in these animals \[see ([@R64],[@R65]) for exceptions\].

Eavesdropping on Brain--Body Communications {#S13}
-------------------------------------------

Interoception is manifested by the conversation between the body and brain via multiple afferent and efferent feedback loops ([@R41],[@R66]). Listening in on this process requires different approaches. Peripheral perturbations are often used to stimulate the afferent bottom-up transfer of information, usually of mechanical ([@R28],[@R47],[@R52],[@R53]), chemical ([@R67]--[@R69]), or hormonal ([@R70]) origin ([Supplemental Table S1](#SD1){ref-type="supplementary-material"}). Central perturbations to probe efferent top-down processes have most typically involved selective regulation of attentional focus ([@R29],[@R71]) and, less commonly, expectancy manipulations such as placebo/sham delivery ([@R72]). Functional magnetic resonance imaging ([@R73]), positron emission tomography ([@R74]), and electroencephalography ([@R75],[@R76]) have provided the primary means of assessing neural circuitry. However, a host of novel tools are capable of inhibiting, stimulating, or modulating the activity of interoceptive brain networks. Noninvasive methods include the application of transcranial magnetic stimulation ([@R77]), transcranial direct and alternating current stimulation ([@R78]), low-intensity focused ultrasound ([@R79]), temporally interfering electric fields ([@R80]), transcutaneous vagus nerve stimulation ([@R81]), presentation of information during different phases of visceral rhythms (e.g., cardiac systole vs. diastole) ([@R82]), and assessment of corticocardiac signaling ([@R83]). An important point is that many of the critical brain structures are difficult to modulate noninvasively because they are located deep within the brain or near the midline. Invasive measures do not share this limitation, and while their implementation is driven by clinical concerns, they can provide important insights. These include implanted vagus nerve stimulation ([@R84]), direct brain stimulation ([@R85]), and intracranial electrode recordings ([@R86],[@R87]). Beyond these perturbation tools, the use of experimental methods to modulate expectancies, such as placebo and sham interventions, is key. These methods will help to determine how sensitive psychiatric and other clinical patients' afferent/efferent feedback loops are to processes requiring integrations of environmental context with body--brain signals (illustrated in the next section). Finally, neurofeedback (e.g., functional magnetic resonance imaging, electroencephalogram) represents an exciting opportunity to participate in the brain--body conversation by simultaneously measuring and modulating brain regions during treatment \[for a noninteroceptive example, see ([@R88])\]. Equipped with these tools, the future looks promising, but to advance progress they need to be paired with better models of brain function.

Computational Theories of Interoception {#S14}
---------------------------------------

Identifying the state of the body represents a problem that cannot be solved by pure sensing because afferent signals from body sensors (interosensations) are not only noisy but often ambiguous ([@R89]). Recent computational theories suggest that interoception deploys Bayesian inference to address this challenge ([@R36],[@R37],[@R44],[@R45],[@R90],[@R91]) ([Figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). Specifically, the brain is assumed to construct a so-called generative model of interosensations that combines a predictive mapping (from hidden bodily states to interosensations) with prior information (beliefs or expectations about bodily states represented as probability distributions). This view is supported by findings that interoceptive perception is strongly shaped by expectations ([@R41],[@R72],[@R92],[@R93]) and by theoretical arguments that suggest Bayesian inference as a unifying principle for interoception and exteroception ([@R37],[@R91]).

Another argument supporting a Bayesian view on interoception is its relation to what constitutes arguably the brain's most fundamental task: the regulation (or control) of bodily states. Put simply, if the brain were unable to resolve the ambiguity of interosensations, it would face difficulties in choosing appropriate actions to protect homeostasis. In information-theoretic terms, the challenge of keeping bodily states within narrow homeostatic ranges corresponds to choosing actions that minimize the long-term average Shannon surprise (entropy) of interosensations ([@R36],[@R91]). Solving this control problem requires knowledge or estimations of current and/or future bodily states and hence inference and predictions/forecasts---two natural domains of generative models.

Eliciting surprise-minimizing (homeostasis-restoring) actions changes the bodily state and thus interosensations. This means that inference and control of bodily states form a closed loop. Inference--control loops that minimize interoceptive surprise can be cast as hierarchical Bayesian models (HBMs). Anatomically, HBMs are plausible candidates given that interoceptive circuitry is structured hierarchically ([@R45],[@R94]). Under general assumptions, HBMs employ a small set of computational quantities---predictions, prediction errors, and precisions ([@R37],[@R95]). These quantities can support surprise minimization in two ways: by adjusting beliefs (probability distributions) throughout the hierarchy \[predictive coding ([@R95])\] or engaging actions that fulfill beliefs about bodily states \[active inference ([@R96])\].

HBMs support both homeostatic (reactive) and allostatic (prospective) control. Reconsidering classical homeostatic set points as beliefs (i.e., probabilistic representations of expected/desired bodily states) enables reactive regulation at the bottom of the hierarchy ([@R36],[@R91]); here, prediction errors elicit reflex-like actions that minimize momentary interoceptive surprise. Allostatic regulation at longer time scales is achieved through modulation of homeostatic beliefs by inferred or forecast states signaled from higher hierarchical levels ([@R36]). Importantly, belief precision determines the force/pace of corrective actions---that is, the tighter the expected range of bodily state, the more vigorous the elicited regulatory action. This offers a novel explanation for psychosomatic phenomena and placebo effects ([@R37]).

In summary, a hierarchical Bayesian perspective unifies interoception and homeostatic/allostatic control under the same computational principles. This provides a conceptual foundation for computational psychosomatics and supports a taxonomy of disease processes ([@R37]). One caveat is that the empirical evidence for hierarchical Bayesian principles of interoception and homeostatic/allostatic control is indirect so far. Studies designed to probe hierarchical Bayesian processes under experimentally controlled homeostatic perturbations will be crucial for finessing (or refuting) current computational concepts of interoception.

PSYCHOPATHOLOGY {#S15}
===============

Interoceptive Psychopathology {#S16}
-----------------------------

Several conceptual and heuristic models have linked dysfunctions of interoception to mental health conditions. Specifically, mood and anxiety disorders have been linked to failures to appropriately anticipate changes in interoceptive states ([@R97]). Eating disorders show behavioral and neural abnormalities in interoceptive processing, particularly in the context of caloric anticipation ([@R72],[@R98]--[@R100]), although it remains unclear whether this is due to altered afferent signaling, altered central sensory processing, abnormal temperament, and/or metacognition. Drug addiction, another condition marked by interoceptive disturbances, has an overlapping neural circuitry and abnormal responses to interoceptive cues ([@R101]--[@R104]). Interoceptive dysfunction also likely plays a role in conditions such as posttraumatic stress disorder and somatic symptom disorders ([@R33]). Other disorders also have interoceptive symptom overlap; however, the specific feature involved may differ according to the disorder or affected individual \[e.g., chronic pain ([@R105],[@R106]), Tourette's syndrome and other tic disorders, borderline personality disorder, obsessive-compulsive disorder, autism spectrum disorder ([@R107]), functional developmental disorders ([@R108])\]. [Table 3](#T3){ref-type="table"} lists diagnostic symptoms and clinical signs indicative of interoceptive dysfunction in several psychiatric disorders. Conditions that have a psychiatric component include fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and functional disorders within medicine (e.g., noncardiac chest pain, functional dysphagia) as well as certain medical disorders (e.g., gastroesophageal reflux, asthma).

Alternatively, one can use a dimensional psychopathology approach to link processes underlying interoceptive dysfunction to psychiatric disorders. Transdiagnostic perspectives such as those provided by the Research Domain Criteria ([@R109]) may be particularly helpful in identifying the potential role played by various interoceptive processes because several of these might not be readily identified at the symptom report level relied on by clinicians and, accordingly, might not have entered into the diagnostic specifications for DSM. This would allow for identification of mechanistic dysfunctions across units of analyses and might bridge the biological gap in current diagnostic classification frameworks by directly probing the links between physiological and psychological dysfunctions. Interoceptive investigations in mental health populations might reveal evidence of 1) attentional bias (e.g., hypervigilance), 2) distorted physiological sensitivity (e.g., blunted or heightened magnitude estimation in response to a perturbation), 3) cognitive bias (e.g., catastrophizing in response to an anticipated stimulus), 4) abnormal sensibility (e.g., tendency to label one's experiences in a particular way), and 5) impaired insight (e.g., poor confidence--accuracy correspondence on a task).

Determining whether interoceptive processes are a cause or consequence of developmental psychopathology, and which factors might affect this development (such as early life stress or pain), will be an important area for future research. Such studies may benefit from the examination of younger ([@R110],[@R111]) or older ([@R112],[@R113]) samples and premorbid identification and longitudinal tracking of individuals ([@R114]). Investigating the role of social cognition/theory of mind in clinically relevant interoceptive inference generation represents another ripe opportunity ([@R115]).

Interoceptive Tests and/or Biomarkers {#S17}
-------------------------------------

Because interoception is fundamentally a process linking body and brain, it is conceivable that objective measures of this process could serve as biological indicators of disease states. However, there is currently limited evidence for interoceptive predictors of diagnostic, prognostic, or treatment status ([@R33],[@R116],[@R117]). Biomarkers, such as those derived from neuroimaging or blood measurements, should be sensitive, specific, and unaffected by cognitive and emotional influences. However, it seems conceivable that the most clinically sensitive interoceptive measures might derive from probes that perturb physiological functions to engage specific metacognitive beliefs and/or expectations about bodily states. Such measures could facilitate differential diagnosis testing by revealing the presence of interoceptive dysfunction of biological (within a physiological system or systems), psychological (e.g., overly precise expectations about bodily states), or metacognitive (e.g., discrepant self-efficacy beliefs with regard to homeostatic/allostatic regulation) origin ([@R37]). This approach could be seen as analogous to a cardiac stress test, such that adequate engagement of the system under ecologically valid conditions is required in order to measure its dysfunction.

The most common application of interoceptive evaluation in current clinical practice occurs during interoceptive exposure psychotherapy for panic disorder ([@R118]). During this procedure, patients self-induce varieties of interoceptive symptoms via low-arousal manipulations (e.g., hyperventilation, performing jumping jacks, spinning in a chair, breathing through a straw) while the clinician monitors their subjective distress level. Unfortunately these manipulations often fail to adequately reproduce the fear response, possibly because the patient retains full control over the stimulation (the patient can quit at any time) and the perturbation remains predictable with minimal uncertainty, raising the question of whether modulating both physiological homeostasis and the perception of controllability might further improve the ecological validity and efficacy of interoceptive exposures ([@R119]). A test to verify successful interoceptive exposure therapy for panic disorder involves completion of a standardized behavioral avoidance paradigm ([@R120]). In this setting, the degree of tolerance to being enclosed in a small dark chamber for 10 minutes might provide behavioral evidence verifying tolerance to triggers of interoceptive dysregulation. There is also experimental evidence that pharmacological interoceptive exposure therapy can reduce anxiety disorder symptom severity either as monotherapy ([@R7],[@R121]--[@R123]) or as an augmentative approach ([@R124]). However, there are few studies of these procedures to date, the impact of such interventions on longer term outcomes (e.g., 6 months or beyond) are unknown, and none of these approaches has translated into clinical practice.

Current Treatments Relevant to Interoception {#S18}
--------------------------------------------

Among the currently available therapies with an interoceptive basis are pharmacotherapies directly modulating interoceptive physiology. Examples include adrenergic blockade (e.g., propranolol) or agonism (e.g., yohimbine), stimulants (e.g., methylphenidate), benzodiazepines, muscle relaxants, and opioids. A second example is cognitive behavioral therapy with exposure and response prevention to reverse or attenuate conditioned fears or form new learned associations. It is helpful in ameliorating cognitive biases in numerous disorders, including depression, obsessive-compulsive disorder, posttraumatic stress disorder (specifically prolonged exposure therapy), irritable bowel syndrome, and chronic pain. Interoceptive exposure is a special example demonstrated to be effective in specific disorders (especially panic disorder). Behavioral activation therapy for depression sometimes includes exposure to experiences with positive interoceptive value. A third example is capnometry-assisted respiratory training. Based on the assumption that sustained hypocapnia resulting from hyperventilation is a key mechanism in the production and maintenance of panic, carbon dioxide capnography-assisted therapy aims to help patients voluntarily increase end-tidal partial pressure of carbon dioxide and tolerate physiological variability associated with panic attacks ([@R125],[@R126]). As a fourth example, mindfulness-based stress reduction, yoga, and other meditation/movement-based treatments may be aimed at improving metacognitive awareness of mind--body connections by systematically attending to sensations of breathing, cognitions, and/or other modulated body states (e.g., muscle stretching) ([@R127]).

Interoceptive Treatments on the Horizon {#S19}
---------------------------------------

Several emerging technologies may have relevance for interoception and mental health, including Floatation-REST (reduced environmental stimulation therapy) and perturbation approaches.

### Floatation-REST {#S20}

This intervention, which systematically attenuates exteroceptive sensory input to the nervous system, also appears to noninvasively enhance exposure to interoceptive sensations such as the breath and heartbeat ([@R128]). Preliminary data suggest that a single 1-hour session has a short-term anxiolytic and antidepressant effect in patients with comorbid anxiety and depression ([@R129]), but further research is needed to evaluate the safety, feasibility, and potential for long-term efficacy in psychiatric populations.

### Perturbation Approaches {#S21}

Minimally invasive tools capable of systematically modulating interoceptive processing, such as inspiratory breathing loads ([@R130]), core body thermomodulation ([@R131],[@R132]), and transcutaneous vagus nerve stimulation ([@R133]), are several approaches awaiting further investigation. Given the hypothesis of noisy baseline afferent signaling, these approaches may systematically enhance the signal-to-noise ratio and facilitate interoceptive learning. A key aspect in discerning clinical efficacy of any perturbation may be the extent to which the patient perceives controllability over the intervention and is willing/able to surrender this parameter in treatment. Interventions in which escape or active avoidance behaviors are directly measurable may provide especially meaningful information ([@R134]).

ROADMAP {#S22}
=======

The Road Ahead {#S23}
--------------

Beyond the issues outlined previously, progress in determining the relevance of interoception for mental health relies on emphasizing the features that distinguish it from other sensory modalities. Interoception seemingly involves a high degree of connectivity within the brain ([@R135]). It appears to be tightly linked to the self and survival through homeostatic maintenance of the body, and by helping us to represent how things are going in the present with respect to the experienced past and the anticipated future. These computations may depend on what has occurred to shape the body's internal landscape, and it is in this regard that learning, and malleability of representations over time, could play important roles.

The conceptual framework for investigating interoception may overlap with other processes, including emotion ([@R136]) and pain ([@R137]), because each is integral for maintaining bodily homeostasis. An important endeavor may involve the identification of which neural systems for interoception, emotion, cognition, and pain are overlapping, interdigitating, or even possibly identical. Additional effort is needed to define the neurophysiological nomenclature, core criteria, common features, developmental aspects, modulating factors, functional consequences, and putative pathophysiologic mechanisms of interoception in mental health disorders.

The current work offers some conceptual distinctions and some mutually agreed-on terminology, with many others still needed. Several low-hanging fruits, as well as promising emerging technologies and tools, have been mentioned. Further empirical work will be critical to delineate how interoception can be mapped to mental health measures, models, and approaches, and benchmarks for success/failure need to be established. Models of interoceptive processing that improve on the traditional stimulus, sensorimotor processing, and response function concepts have been described, but these models remain theoretical and await further testing. Therefore, the current document is best viewed as a work in progress.

Supplementary Material {#S24}
======================
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Visceroception has classically referred to the perception of bodily signals arising specifically from visceral organs, such as the heart, lungs, stomach, intestines, and bladder, along with other internal organs in the trunk of the body ([@R19]). It did not include organs such as the skin and skeletal muscle, in contrast to contemporary definitions of interoception that typically encompasses signals from both the viscera and all other tissues that relay a signal to the central nervous system about the current state of the body, including the skin and skeletal/smooth muscle fibers, via lamina I spinothalamic afferents ([@R41],[@R138],[@R139]).
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![**(A)** Number of English language publications per year on interoception from PubMed, PsycINFO, and Institute for Science Information Web of Knowledge. The timeline starts in 1905, one year before the publication of Charles Sherrington's book, The Integrative Action of the Nervous System, which first defined the concept of interoception. Key historical events relevant to interoception science are superimposed. **(B)** Publications per year on interoception vs. those investigating features of interoception that do not specifically refer to the term. These latter publications are more numerous and arise mainly from basic neuroscience, physiology, and subspecialty disciplines within the biomedical field. Note the use of a logarithmic scale in the second panel. \[Figure reproduced and modified with permission from Khalsa and Lapidus ([@R33]).\]](nihms973241f1){#F1}

![**(A)** Cardiac interoceptive processing measures and feature loading. This illustrates how the most commonly used heartbeat perception tasks differentially measure interoceptive features. \[Figure reproduced and modified with permission from Khalsa and Lapidus ([@R33]).\] **(B)** Multisystem interoceptive processing measures and feature loadings: Example of hypothetical approaches to measuring interoceptive processing across multiple systems. Approaches that perturb the state of the body are recommended, as are convergent approaches such as combined assessments of interoceptive attention and perturbation. **(C)** Central neural integration of interoceptive rhythms. Interoceptive rhythms vary considerably across the different systems of the body. They exhibit complex characteristics and are hierarchically integrated within discrete regions of the central nervous system. \[Figure modified, with permission, from Petzschner *et al.* ([@R37]).\] **(D)** Interoceptive rhythms vary in both amplitude and frequency. The top trace illustrates a hypothetical example of an amplitude modulation signal superimposed on a static frequency. The middle trace illustrates a hypothetical frequency modulation signal superimposed on a static amplitude. The bottom trace illustrates a hypothetical signal change involving both amplitude and frequency modulations that are temporally correlated. GI, gastrointestinal; GU, genitourinary.](nihms973241f2){#F2}

![**(A)** Example of one possible form of a general inference--control loop illustrated within a hierarchical Bayesian model. **(B)** Highly schematic example of illustrating that both interoceptive information and exteroceptive information are concurrently integrated to inform perceptual representations and action selection with respect to internally directed (e.g., visceromotor, autonomic) and externally directed (e.g., skeletomotor) actions. **(C)** General nodes that comprise a peripheral and central neural circuit for hierarchically integrating afferent interoceptive information into homeostatic reflexes, sensory and meta-cognitive representations, and allostatic regulators (predictions). ACC, anterior cingulate cortex; AIC, anterior insular cortex; MC, metacognitive layer; MIC, midinsular cortex; OFC, orbitofrontal cortex; PE, prediction error; PIC, posterior insular cortex; SGC, subgenual cortex. \[Panels **(A)** and **(B)** reproduced, with permission, from Petzschner *et al.* ([@R37]). Panel **(C)** adapted, with permission, from Stephan *et al.* ([@R36]).\]](nihms973241f3){#F3}

![**(A)** Active inference implementation according to the Embodied Predictive Interoception Coding model. Agranular visceromotor cortices, including the cingulate cortex, posterior ventral medial prefrontal cortex, posterior orbitofrontal cortex, and ventral anterior insula, estimate the balance among autonomic, metabolic, and immunological resources available to the body and its predicted requirements. These agranular visceromotor cortices issue allostatic predictions to hypothalamus, brainstem, and spinal cord nuclei to maintain a homeostatic internal milieu and simultaneously to the primary interoceptive sensory cortex in the mid and posterior insula. The interoceptive sensory cortex in the granular mid and posterior insula sends reciprocal prediction error signals back to the agranular visceromotor regions to modify the predictions. Under usual circumstances, these agranular regions are relatively insensitive to such feedback, which explains why interoceptive predictions are fairly stable in the face of body fluctuations. One hypothesis of the role of interoception in mental illness is that interoceptive input (i.e., posteriors) becomes increasingly decoupled from interoceptive predictions issued by the agranular visceromotor cortex (priors), leading to increased interoceptive prediction error signals. This decoupling may present in the brain as "noisy afferent interoceptive inputs" ([@R97]). **(B)** Proposed intracortical architecture and intercortical connectivity for interoceptive predictive coding. The granular cortex contains six cell layers including granule cells, which are excitatory neurons that amplify and distribute thalamocortical inputs throughout the column. The granular cortex is structurally similar to the neocortex and therefore more recently evolved than the agranular and dysgranular cortices. Within the insula, the granular cortex is present in the mid and posterior sectors. AC, anterior cingulate; PL, prelimbic cortex. \[Figures reproduced, with permission, from Barrett and Simmons ([@R45]).\]](nihms973241f4){#F4}

###### 

Physiological Processes Often Ascribed to Interoception

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Nonpainful
   Cardiovascular, respiratory, gastrointestinal (esophageal, gastric, intestinal, colorectal), bladder, hunger, thirst, blood/serum (pH, osmolality, glucose), temperature, vasomotor flush, air hunger, muscle tension, shudder, itch, tickle, genital sensation, sensual touch, fatigue
  Painful
   Visceral: kidney stone, pleuritic, angina, pericardial, bowel ischemia, pelvic, sickle crisis
   Somatic: abscess/boil, bruising, myalgia, inflammation (systemic/laceration), headache
   Skeletal: fractured/bruised bone, stress fracture, inflammatory/mechanical joint pain
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Several key distinctions are that interoceptive sensing 1) may be painful or nonpainful, 2) occurs across the spectra of high/low arousal and negative/positive valence, 3) usually occurs outside of conscious awareness (with the exception of pain sensations), and 4) is often (but not always) consciously experienced during instances of homeostatic perturbation.

###### 

Features of Interoceptive Awareness

  Feature                  Definition
  ------------------------ -----------------------------------------------------------------------------------------------------
  Attention                Observing internal body sensations
  Detection                Presence or absence of conscious report
  Magnitude                Perceived intensity
  Discrimination           Localize sensation to a specific channel or organ system and differentiate it from other sensations
  Accuracy (Sensitivity)   Correct and precise monitoring
  Insight                  Metacognitive evaluation of experience/performance (e.g., confidence--accuracy correspondence)
  Sensibility              Self-perceived tendency to focus on interoceptive stimuli (trait measure)
  Self-report Scales       Psychometric assessment via questionnaire (state/trait measure)

For some examples of paradigms assessing each feature, see [Supplemental Table S1](#SD1){ref-type="supplementary-material"}.

###### 

Diagnostic Symptoms and Clinical Signs Indicating Interoceptive Dysfunction in Some Psychiatric Disorders

  Psychiatric Disorder                       Symptoms                                                                                                   Signs                                                                                                                          Sample Studies
  ------------------------------------------ ---------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------ ---------------------------
  Panic Disorder                             Palpitations, chest pain, dyspnea, choking, nausea, dizziness, flushing, depersonalization/derealization   Elevated heart rate and/or blood pressure, exaggerated escape, startle, and flinching                                          ([@R5],[@R140],[@R141])
  Depression                                 Increased or decreased appetite, fatigue, lethargy                                                         Weight gain, weight loss, psychomotor slowing                                                                                  ([@R142],[@R143])
  Eating Disorders                           Hunger insensitivity, food anxiety, gastrointestinal complaints                                            Severe food restriction, severe weight loss, binging, purging, compulsive exercise                                             ([@R72],[@R98])
  Somatic Symptom Disorders                  Multiple current physical and nociceptive Symptoms                                                         Medical observations do not correspond with symptom report                                                                     ([@R144],[@R145])
  Substance Use Disorders                    Physical symptoms associated with craving, intoxication, and/or withdrawal (drug specific)                 Elevated/decreased: heart rate, respiratory rate, and/or blood pressure, pupil dilation/constriction, others (drug specific)   ([@R101],[@R146],[@R147])
  Posttraumatic Stress Disorder              Autonomic hypervigilance, depersonalization/derealization                                                  Exaggerated startle, flinching, and/or escape responses, elevated heart rate and/or blood pressure                             ([@R148])
  Generalized Anxiety Disorder               Muscle tension, headaches, fatigue, Gastrointestinal complaints, pain                                      Trembling, twitching, shaking, sweating, nausea, exaggerated startle                                                           ([@R149],[@R150])
  Depersonalization/Derealization Disorder   Detachment from one's body, head fullness, tingling, lightheadedness                                       Physiological hyporeactivity to emotional stimuli                                                                              ([@R151],[@R152])
  Autism Spectrum Disorders                  Skin hypersensitivity                                                                                      Selective clothing preferences                                                                                                 ([@R107],[@R153],[@R154])
